126 related articles for article (PubMed ID: 32777139)
1. Will GRECCAR 2 be a game changer for the management of rectal cancer?
Sun Myint A; Dhadda A; Rao C; Sripadam R; Gerard JP
Colorectal Dis; 2020 Dec; 22(12):2330. PubMed ID: 32777139
[No Abstract] [Full Text] [Related]
2. Chemoradiotherapy and Local Excision for Organ Preservation in Early Rectal Cancer-The End of the Beginning?
Garcia-Aguilar J
JAMA Surg; 2019 Jan; 154(1):54-55. PubMed ID: 30304376
[No Abstract] [Full Text] [Related]
3. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
[TBL] [Abstract][Full Text] [Related]
4. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
[TBL] [Abstract][Full Text] [Related]
5. Local excision after preoperative chemoradiation for T2 and T3 rectal cancers: is the wait over?
Dossa F; Acuna SA; Baxter NN
Lancet Gastroenterol Hepatol; 2020 May; 5(5):422-424. PubMed ID: 32043981
[No Abstract] [Full Text] [Related]
6. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
[TBL] [Abstract][Full Text] [Related]
7. Advances in organ preserving strategies in rectal cancer patients.
Stijns RCH; Tromp MR; Hugen N; de Wilt JHW
Eur J Surg Oncol; 2018 Feb; 44(2):209-219. PubMed ID: 29275912
[TBL] [Abstract][Full Text] [Related]
8. Organ preservation in rectal cancer: have all questions been answered?
Marijnen CA
Lancet Oncol; 2015 Jan; 16(1):e13-22. PubMed ID: 25638548
[TBL] [Abstract][Full Text] [Related]
9. What is most relevant in preoperative rectal cancer chemoradiotherapy - the chemotherapy, the radiation dose or the timing to surgery?
Glimelius B
Acta Oncol; 2016 Dec; 55(12):1381-1385. PubMed ID: 27879164
[No Abstract] [Full Text] [Related]
10. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic evaluation and surgical strategy after neoadjuvant chemoradiotherapy for rectal cancer].
Ma L; Wang Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):23-28. PubMed ID: 29354895
[TBL] [Abstract][Full Text] [Related]
13. Longer Intervals from Neoadjuvant Therapy to Rectal Cancer Surgery: The Clock is Ticking….
Fernandez LM; Perez RO
Ann Surg Oncol; 2019 Jul; 26(7):1957-1958. PubMed ID: 30945045
[No Abstract] [Full Text] [Related]
14. Effects of Preoperative Chemoradiotherapy on the Likelihood of Sphincter Preservation Surgery in Locally Advanced Distal Rectal Cancer: A Longitudinal Study Based on Pelvic Magnetic Resonance Imaging.
Ihn MH; Kim YH; Kim DW; Oh HK; Lee SY; Park JT; Son IT; Park JH; Lee YJ; Kim JW; Lee KW; Kim JH; Shin E; Lee HS; Ahn S; Kang SB
Ann Surg Oncol; 2015 Jul; 22(7):2159-67. PubMed ID: 25503346
[TBL] [Abstract][Full Text] [Related]
15. Rectal cancer: No benefit for local excision over rectal excision.
Dickson I
Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):450. PubMed ID: 28676709
[No Abstract] [Full Text] [Related]
16. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
[No Abstract] [Full Text] [Related]
17. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic en bloc total mesorectal excision post chemoradiotherapy - a video vignette.
Panteleimonitis S; Siddiqi N; Amjad T; Figueiredo N; Parvaiz A
Colorectal Dis; 2017 Jul; 19(7):697-698. PubMed ID: 28510316
[No Abstract] [Full Text] [Related]
19. Adjuvant chemotherapy for rectal cancer.
Thornton M; Rooney PS
Lancet Oncol; 2014 May; 15(6):e196. PubMed ID: 24807864
[No Abstract] [Full Text] [Related]
20. Adjuvant chemotherapy for rectal cancer.
Valsecchi ME
Lancet Oncol; 2014 May; 15(6):e195. PubMed ID: 24807863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
